COGSTATE LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.385 AUD | +4.53% |
|
+6.54% | -4.15% |
| Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| Feb. 22 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
Evolution of the average Target Price on Cogstate Limited
Price target over the last 5 years
History of analyst recommendation changes
252482155679563821ddbcc2.l-TdKVWssQ6CKT8xFW6Dgqi78qBZIXkRr5XS0Sbe6QU.3rblQjHB9Wu3fwdgRAHn9fzdp_EqaSBd2taIgRSVmmDxgOh-JJ_2XsZLTA~2a127c5df1ad85b5867cf2ba7d293941
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.325
AUD
Average target price
1.8
AUD
Spread / Average Target
+35.85%
High Price Target
1.8
AUD
Spread / Highest target
+35.85%
Low Price Target
1.8
AUD
Spread / Lowest Target
+35.85%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CGS Stock
- Consensus Cogstate Limited
